Bharat serums and vaccines limited - Latest News Update, Information, Photos & Videos on Bharat serums and vaccines limited at Lokmat Times

(NYSE: VEEV) today announced one of India's fastest-growing biopharma companies, Bharat Serums and Vaccines Limited (BSV), is standardizing on to accelerate its end-to-end content lifecycle for scientific and promotional materials. BSV is adopting a scalable digital content platform for streamlined approvals and better content reuse to future-proof its operations in preparation for expansion into global markets.For over five decades, BSV has developed a range of biological, biotech, and pharmaceutical products for women's health, infertility (IUI/IVF), and critical, and emergency care."At BSV, we remain committed to innovation and research to deliver treatments and cures that serve our patients better," said Dr Swashraya Shah, Chief Medical Officer at BSV. "With Vault PromoMats, organizations now have the ability to prioritize and share scientific digital content with physicians in real-time, while ensuring compliance and effective data asset management. Vault PromoMats also assists in content analytics to increase effectiveness.""We are excited that BSV has standardized on Vault PromoMats to easily publish approved assets to digital channels and to accelerate its time to market through content reuse," said Anantha Nema, India country manager, Veeva Systems. "With a digital content platform, biopharmas in India can optimize their promotional material review cycles to keep up with the increased demand for timely information."helps life sciences companies speed the creation, review, and distribution of compliant content. Built-in digital asset management enables content reuse and reduces spend on promotional materials. Marketing teams can easily publish and withdraw content from digital channels as needed to ensure only approved assets are in use. Vault PromoMats also supports accelerated content approval and time to market through streamlined medical, legal, and regulatory reviews, and offers visibility into industry benchmarks and activities across assets to drive content strategy.Additional InformationFor more on Veeva Vault PromoMats, visit: Connect with Veeva on LinkedIn: Follow @veevasystems on Twitter:This story is provided by BusinessWire India.will not be responsible in any way for the content of this article. (ANI/BusinessWire India)( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Pahalgam Terror Attack

Tahawwur Rana

IPL 2025

CM Devendra Fadnavis

Mumbai Local

Weather Update

Bharat Serums And Vaccines LimitedFOLLOW

Bharat serums and vaccines limited, Latest News

Business :Bharat Serums and Vaccines to invest Rs 200 crore in Genome Valley

Biopharmaceutical firm Bharat Serums and Vaccines Limited (BSV) on Tuesday said it would invest Rs 200 crore in the development of injectable and vaccine manufacturing facility at Genome Valley, India's first organised cluster for Life Sciences R&D a ...

Business :Leading India biopharma standardizes on Veeva Vault PromoMats to speed scientific content distribution

Veeva Systems (NYSE: VEEV) today announced one of India's fastest-growing biopharma companies, Bharat Serums and Vaccines Limited (BSV), is standardizing on Veeva Vault PromoMats to accelerate its end-to-end content lifecycle for scientific and promo ...